Sökresultat - José Cabeza

Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress av Anabel Torrente-López, Jesús Hermosilla, Antonio Salmerón-García, José Cabeza, Natalia Navas

Connect to this object online.

Study and ICH validation of a reverse-phase liquid chromatographic method for the quantification of the intact monoclonal antibody cetuximab av Antonio Martínez-Ortega, Agustín Herrera, Antonio Salmerón-García, José Cabeza, Luis Cuadros-Rodríguez, Natalia Navas

Connect to this object online.

Comprehensive Analysis of Cetuximab Critical Quality Attributes: Impact of Handling on Antigen-Antibody Binding av Alicia Torres-García, Anabel Torrente-López, Jesús Hermosilla, Amparo Hernández, Antonio Salmerón-García, José Cabeza, Natalia Navas

Connect to this object online.

Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes av Natalia Navas, Jesús Hermosilla, Anabel Torrente-López, José Hernández-Jiménez, Jose Cabeza, Raquel Pérez-Robles, Antonio Salmerón-García

Connect to this object online.

Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of <i>DPYD</i> Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study av Xando Díaz-Villamarín, María Martínez-Pérez, María Teresa Nieto-Sánchez, Gabriela Ruiz-Tueros, Emilio Fernández-Varón, Alicia Torres-García, Beatriz González Astorga, Isabel Blancas, Antonio J. Iáñez, José Cabeza-Barrera, Rocío Morón

Connect to this object online.

Gut Microbiota Composition Can Predict Colonization by Multidrug-Resistant Bacteria in SARS-CoV-2 Patients in Intensive Care Unit: A Pilot Study av Jorge García-García, Patricia Diez-Echave, María Eugenia Yuste, Natalia Chueca, Federico García, Jose Cabeza-Barrera, Emilio Fernández-Varón, Julio Gálvez, Manuel Colmenero, Maria Elena Rodríguez-Cabezas, Alba Rodríguez-Nogales, Rocío Morón

Connect to this object online.